Hiroshi Kasamatsu
Overview
Explore the profile of Hiroshi Kasamatsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasegawa T, Utsunomiya A, Chino T, Kasamatsu H, Shimizu T, Matsushita T, et al.
Arthritis Res Ther
. 2024 May;
26(1):94.
PMID: 38702742
Background: Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular injury and inflammation, followed by excessive fibrosis of the skin and other internal organs, including the lungs. CX3CL1 (fractalkine),...
2.
Ishikawa Y, Tanaka N, Asano Y, Kodera M, Shirai Y, Akahoshi M, et al.
Nat Commun
. 2024 Jan;
15(1):319.
PMID: 38296975
Here we report the largest Asian genome-wide association study (GWAS) for systemic sclerosis performed to date, based on data from Japanese subjects and comprising of 1428 cases and 112,599 controls....
3.
Fujisaki M, Kasamatsu H, Nishimura K, Yoshida Y, Muneishi Y, Yamaguchi T, et al.
J Dermatol
. 2023 Oct;
51(2):301-306.
PMID: 37830399
Dermatomyositis constitutes a heterogeneous group of autoimmune inflammatory conditions with a wide variety of clinical outcomes. The symptomatic heterogeneity carries skin, muscle, and joint manifestations; pulmonary and cardiac involvements; and...
4.
Kasamatsu H, Chino T, Hasegawa T, Utsunomiya N, Utsunomiya A, Yamada M, et al.
Arthritis Res Ther
. 2023 Aug;
25(1):156.
PMID: 37626391
Background: Systemic sclerosis (SSc) is a connective tissue disease that is characterized by fibrosis in the skin and internal organs, such as the lungs. Activated differentiation of progenitor cells, which...
5.
Iino S, Baba N, Hasegawa T, Kasamatsu H, Oyama N, Tokunaga T, et al.
Front Surg
. 2022 Sep;
9:915731.
PMID: 36157405
In older patients with facial basal cell carcinoma (BCC) or squamous cell carcinoma (SCC), surgery should be aimed to reduce treatment-related sequelae and burden with achieving local tumor care. Therefore,...
6.
Hasegawa T, Oyama N, Kasamatsu H, Chino T, Taga M, Hasegawa M
J Dermatol
. 2022 Sep;
49(12):e453-e454.
PMID: 36052729
No abstract available.
7.
Utsunomiya A, Chino T, Kasamatsu H, Hasegawa T, Utsunomiya N, Luong V, et al.
Arthritis Res Ther
. 2022 Apr;
24(1):94.
PMID: 35488265
Background: Systemic sclerosis (SSc) is a collagen disease that exhibits intractable fibrosis and vascular injury of the skin and internal organs. Transforming growth factor-β (TGF-β)/Smad signaling plays a central role...
8.
Kasamatsu H, Oyama N, Hasegawa M, Oku Y, Inoue G, Kimura M, et al.
J Dermatol
. 2020 Oct;
48(2):237-241.
PMID: 33073392
Pancreatic panniculitis (PP) is a rare clinical variant of subcutaneous fat necrosis, developing in patients with a variety of pancreatic diseases such as acute or chronic pancreatitis, tumors and cysts....